Cyclerion Therapeutics Merger Agreement Filed

Cyclerion Therapeutics, Inc. filed an SEC 8-K exhibit containing an Agreement and Plan of Merger and Reorganization dated April 1, 2026.

The exhibit lists KORSANA BIOSCIENCES, INC. and two merger sub entities (Cariboos Merger Sub Corp. and Cariboos Merger Sub II, LLC) as parties to the merger with Cyclerion Therapeutics. The document includes provisions covering merger mechanics, equity conversion, contingent value rights, and closing conditions such as regulatory approvals and stockholder approval.